NCT07040826View on ClinicalTrials.gov

Lifitegrast Eye Drops in Healthy Subjects：Phase I Study

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 6, 2022

Primary Completion Date

December 19, 2022

Study Completion Date

April 10, 2023

Conditions
Dry Eye Syndromes
Interventions
DRUG

Xiidra

Administered on Day 1 to subjects in Group B, and on Day 8 to subjects in Group A as part of a crossover study design.

DRUG

Lifitegrast

Administered on Day 1 to subjects in Group A, and on Day 8 to subjects in Group B as part of a crossover study design.

Trial Locations (1)

Unknown

The First Affiliated Hospital of University of Science and Technology of China, Hefei

All Listed Sponsors
lead

Qilu Pharmaceutical Co., Ltd.

INDUSTRY